Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
€ 33.88 -1.14%

Quartalsbericht 2024-Q3
hinzugefügt 04.11.2024

report update icon

Supernus Pharmaceuticals Kennzahlen 2011-2024 | SUPN

Kennzahlen Jährlich Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

32.7 30.7 12.2 10.9 17.4 35.7 13.8 38.4 18.1 -3.4 -2.9 -

P/S

3.0 2.8 3.0 3.1 4.7 6.8 5.9 3.7 2.9 25.9 90.7 -

EPS

1.1 1.0 2.4 2.2 2.1 1.1 1.8 0.3 -0.3 -2.9 -2.7 31.4

EV (Enterprise Value)

2.71 B 2.31 B 2.02 B 1.61 B 2.26 B 2.1 B 1.31 B 575 M 389 M 356 M 130 M -4.26 M

EBITDA per Share

2.45 2.23 3.65 2.96 2.91 2.12 1.14 0.391 0.595 -1.92 -2.37 -

EV/EBITDA

19.1 8.5 9.0 13.6 18.0 21.1 27.5 13.9 -5.1 -2.8 -

PEG

4.93 1.41 0.18 7.72 0.2 -0.92 0.03 -1.06 0.16 0.51 0.02 -

P/B

2.2 2.0 2.1 2.1 4.3 7.6 6.6 4.5 5.0 9.3 2.3 -

P/CF

17.0 12.9 11.2 8.8 15.1 18.1 19.3 17.9 50.3 -5.2 -2.8 -

ROE %

6.85 6.55 17.04 18.99 24.50 21.42 47.57 11.79 27.85 -275.74 -80.40 -

ROA %

3.57 3.16 8.44 9.74 11.35 13.50 29.47 7.43 14.45 -83.13 -49.24 -

ROCE %

5.20 10.54 23.32 14.86 17.69 33.02 23.69 13.32 22.02 -73.20 -59.39 -

Current Ratio

2.1 1.9 2.0 2.9 3.1 1.9 1.9 1.9 4.0 3.7 4.0 -

DSO

86.0 91.2 80.0 81.2 91.9 79.2 70.5 65.5 51.6 168.2 166.5 -

DIO

371.4 326.5 260.8 583.4 609.9 391.1 511.6 545.4 852.0 2364.6 - -

DPO

41.6 37.6 56.7 222.2 75.9 164.2 245.3 186.9 118.1 6054.9 - -

Betriebszyklus

457.4 417.7 340.8 664.5 701.8 470.3 582.1 610.9 903.7 2532.7 - -

Finanzkreislauf

415.8 380.1 284.1 442.4 625.8 306.1 336.8 424.0 785.6 -3522.2 - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.7 0.36 - - -0.29 -0.02 0.31 - 0.03 0.15 0.48 - 0.41 0.45 0.11 - 0.76 0.66 0.41 0.63 0.55 0.62 0.35 0.5 0.54 0.59 0.51 0.27 0.31 0.34 0.21 0.29 1.25 0.21 0.1 0.14 0.08 0.05 0.02 0.09 -0.06 0.08 -0.38 -0.65 -0.78 -0.89 -0.6 -0.51 -0.55 -0.61 -6.05 2.88 -6.64 -5.17 -7.48

EBITDA per Share

0.75 0.42 0.32 - 0.16 -0.31 0.47 - -0.01 0.23 0.44 - 0.99 0.89 0.37 - 1.31 0.96 0.59 0.78 0.85 0.88 0.52 0.76 0.82 0.76 0.64 0.67 0.56 0.56 0.35 0.33 0.44 0.26 0.14 - 0.12 0.09 0.1 - - 0.1 -0.32 - -0.54 -0.49 -0.57 - -0.48 -0.52 -4.57 - -5.81 -5 -5.64

ROE %

4.16 -1.41 -3.58 0.02 0.22 2.18 3.20 4.23 6.89 9.35 11.43 6.44 11.81 14.51 16.15 12.91 18.48 17.95 18.80 18.99 19.14 20.48 21.76 24.50 23.89 23.68 23.38 21.42 23.78 50.05 48.91 47.57 47.89 20.10 17.52 15.84 17.36 7.09 8.81 -13.82 -90.08 -156.26 -242.49 -275.74 -232.25 -183.67 -119.31 -80.40 811.18 731.51 670.79 569.89 -103.08 -78.12 -117.01

ROA %

3.15 -0.96 -2.54 -0.36 -0.26 1.09 1.62 2.13 3.52 4.80 5.84 3.27 5.93 7.20 8.00 6.39 9.25 9.08 9.59 9.74 9.54 9.91 10.24 11.35 11.92 12.82 13.76 13.50 14.90 31.12 30.33 29.47 28.47 10.58 8.56 7.39 6.53 2.72 3.76 -7.94 -30.89 -50.87 -77.85 -83.13 -77.32 -69.96 -55.96 -49.24 117.70 113.93 110.85 100.16 -18.12 -13.73 -20.56

ROCE %

6.97 3.80 -0.47 -0.45 -0.63 -1.70 1.56 1.41 5.43 9.63 12.63 10.12 17.65 21.17 22.94 17.55 24.40 23.54 24.58 24.95 26.89 28.49 29.23 31.88 35.93 36.01 37.87 37.21 32.87 34.87 31.19 28.27 25.55 20.99 19.28 14.73 12.92 5.33 6.23 -15.35 -66.68 -116.19 -167.71 -151.09 -172.44 -142.47 -112.29 -51.11 -156.11 -239.76 -312.59 -291.32 -105.00 -88.91 -97.41

Current Ratio

4.0 3.7 3.5 3.6 3.5 3.5 2.0 2.1 2.0 2.0 2.0 1.9 2.1 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 1.9 1.9 2.7 2.7 2.7 2.7 2.6 2.6 2.6 2.6 1.9 1.9 1.9 1.9 1.4 1.4 2.1 2.1 1.4 1.4 1.4 1.4 2.6 2.6 2.6 2.6 1.2 1.2 1.2 1.2

DSO

77.4 81.4 92.7 - 82.5 94.3 91.7 - 82.9 81.3 88.0 - 83.3 85.3 93.4 - 82.9 101.4 109.6 79.3 78.0 76.1 101.6 81.0 91.2 94.3 85.0 67.7 74.4 78.9 84.9 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113.2 44.6 366.9 1641.2 1572.0 21.4 250.7 - 28.1 139.1 - - -

DIO

342.9 364.8 426.6 - 405.1 393.1 355.3 - 296.2 387.3 444.6 - 299.1 198.0 300.7 - 206.2 525.8 823.6 - 504.2 600.8 647.6 - 556.5 635.7 584.1 - 350.0 385.3 512.2 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

28.6 48.5 45.8 - 18.1 34.5 43.0 - 90.9 106.7 55.1 - 41.3 24.0 36.9 - 26.2 66.9 179.0 - 192.0 228.8 165.2 - 69.3 79.2 139.7 - 146.9 161.8 230.5 - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

420.2 446.1 519.3 - 487.6 487.4 447.0 - 379.1 468.6 532.6 - 382.3 283.3 394.1 - 289.0 627.3 933.3 79.3 582.2 677.0 749.1 81.0 647.7 730.1 669.1 67.7 424.4 464.2 597.1 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113.2 44.6 366.9 1641.2 1572.0 21.4 250.7 - 28.1 139.1 - - -

Finanzkreislauf

391.6 397.7 473.5 - 469.5 452.9 404.1 - 288.2 361.9 477.5 - 341.1 259.3 357.1 - 262.8 560.4 754.3 79.3 390.2 448.1 584.0 81.0 578.4 650.9 529.4 67.7 277.5 302.5 366.6 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113.2 44.6 366.9 1641.2 1572.0 21.4 250.7 - 28.1 139.1 - - -

Alle Zahlen in USD-Währung